Anti HLA class Ⅰ-A, B, C, Mouse Monoclonal antibody, (EMR8-5), HRP
Product#: FNK-AB-46-H
$911.54
Availability:
Ships in 1-2 Weeks
Anti HLA class Ⅰ-A, B, C, Mouse Monoclonal antibody, (EMR8-5), HRP
General information
| Cat. No. | ：FNK-AB-46-H |
| Size | ：100 µl |
| Clone No. | ：EMR8-5 |
| Specificity | ：Heavy chains of HLA-A, HLA-B, HLA-C |
| Immunogen | ：Recombinant HLA-A*2402 extracellular domain |
| Conjugation | ：HRP |
| Isotype | ：IgG1 |
| Application | ：Immunohistochemistry (formalin-fixed tissue ), Western blotting, Optimal dilutions / concentrations should be determined by the user. |
| Buffer | ：Phosphate buffered saline pH7.4 , 0.05% ProClin 300 |
| Storage | ：Store at 2～8℃. Do not freeze |
References
- Torigoe T, Asanuma H, Shimozawa K, et al. Immunohistochemical analysis of HLA class I expression in tumor tissues revealed unusually high frequency of down-regulation in breast cancer tissues. submitted
- Tsukahara T, Kawaguchi S, Torigoe T, et al Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5. Cancer Sci 97: 1374-1380, 2006
- Kitamura H, Torigoe T, Honma I, et al Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer. Clin Cancer Res 12: 4641-4644, 2006
- Komori H, Nakatsura T, Senju S, et al Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin Cancer Res 12: 2689-2697, 2006
- Kitamura H, Torigoe T, Honma I, et al Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy. Urology 67: 955-959, 2006
| Aliases for HLA-A Gene | Aliases for HLA-B Gene | Aliases for HLA-C Gene |
|
|
